References
- Soda M , ChoiYL, EnomotoM et al. Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer. Nature 448(7153) , 561–566 (2007).
- Takeuchi K , SodaM, TogashiY et al. RET, ROS1 and ALK fusions in lung cancer. Nat. Med.18(3) , 378–381 (2012).
- Kwak EL , BangY, CamidgeR et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N. Engl. J. Med. 363 , 1693–1703 (2010).
- Mardis ER . A decade‘s perspective on DNA sequencing technology. Nature470(7333) , 198–203 (2011).
References
- Butts CA , DingK, SeymourL et al. Randomized Phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10. J. Clin. Oncol. 28(1) , 29–34 (2010).
- Arriagada R , DunantA, PignonJP et al. Long-term results of the international adjuvant lung cancer trial evaluating adjuvant cisplatin-based chemotherapy in resected lung cancer. J. Clin. Oncol. 28(1) , 35–42 (2010).
- Pignon JP , TribodetH, ScagliottiGV et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE collaborative group. J. Clin. Oncol. 26(21) , 3552–3559 (2008).
References
- Siegel R , NaishadhamD, JemalA. Cancer statistics, 2013. CA Cancer J. Clin.63 , 11–30 (2013).
- Brock MV , HookerCM, Ota-MachidaE et al. DNA methylation markers and early recurrence in stage I lung cancer. N. Engl. J. Med. 358 , 1118–1128 (2008).
- De Fraipont F , LevalletG, CreveuilC et al. An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial. Clin. Cancer Res. 18 , 2976–2986 (2012).
- Butts CA , DingK, SeymourL et al. Randomized Phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small cell lung cancer: updated survival analysis of JBR-10. J. Clin. Oncol. 28 , 29–34 (2010).
- Yanaihara N , CaplenN, BowmanE et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9 , 89–198 (2006).
- Lu Y , GovindanR, WangL et al. microRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer. Carcinogenesis 5 , 1046–1054 (2012).